Medline ® Abstract for Reference 80
Incidence of scalp metastases in breast cancer: a retrospective cohort study in women who were offered scalp cooling.
Lemieux J, Amireault C, Provencher L, Maunsell E
Breast Cancer Res Treat. 2009;118(3):547.
Scalp cooling is an intervention used to decrease the degree of chemotherapy-induced alopecia. The objective is to determine the incidence of scalp metastases among women with early breast cancer who received neoadjuvant or adjuvant chemotherapy. We conducted a retrospective cohort study of women with breast carcinoma diagnosed between June 1, 1998 and June 30, 2002. The median follow-up was 5.8 years (+/-1.7) for the scalp cooling group (n = 553) and 5.4 years (+/-1.7) for the non-scalp cooling group (n = 87). The incidence of scalp metastases was 1.1% (6 cases out of 553 patients) among women who used scalp cooling in the neoadjuvant or adjuvant setting and 1.2% also (1 case out of 87 patients) among women who did not use scalp cooling in the neoadjuvant or adjuvant setting. The incidence of scalp metastases was low and no case presented as an isolated site of relapse.
Service d'hématologie et oncologie, Centre des maladies du sein Deschênes-Fabia and Unitéde recherche en santédes populations of the Centre hospitalier affiliéuniversitaire de Québec, UniversitéLaval, 1050 Chemin Ste-Foy, Room JS1-01, Québec, QC, G1S 4L8, Canada. email@example.com